Consult SteadyMD, a telehealth provider to determine if an authorized COVID-19 oral antiviral treatment option is right for you

  • If you’re 18 or older, a telehealth provider will assess your risk status and COVID-19 symptoms to determine if you are eligible for treatment

  • Consult with a telehealth provider in just 2 hours* starting at $18

  • Phone or video call consultation (options vary by state)

  • Treatments are made available at no charge **

    (Pharmacy dispensing fees may apply)

These treatments are authorized to help reduce progression to severe COVID-19, including hospitalization or death.

Get started
Powered by

*Assessments are completed within 2 hours from 8am–8pm CT, 7 days a week. Requests out of hours will be completed by 10am CT the next day.

How it works

  1. Create a SteadyMD account
  2. Answer some questions about you and your health
  3. A SteadyMD healthcare provider will review the health information you provide (starting at $18 out of pocket)
  4. If prescribed, pick up your prescription at pharmacy of your choice

By using this service you agree to Ada’s Terms and Conditions.

Great guided questions and self-reported symptoms to understand possible causes.
S. Kacherovich

Hi, we’re Ada

We’ve been working hard to improve health outcomes since 2016. Built by doctors and scientists and powered by a 12 million-strong userbase, our medical AI simplifies healthcare journeys and helps people take care of themselves.

symptom assessments

The world's trusted partner for clinically driven AI.

Sutter Health
Fondation Botnar
Dr. Michal Stebnicki

Dr. Michal Stebnicki
Senior Medical Knowledge Engineer

Dr. Claire Novorol

Dr. Claire Novorol
Co-founder & Chief Medical Officer

Ewelina Türk

Ewelina Türk
SVP Medical Product

Medical quality is in our DNA

There are no shortcuts to becoming a qualified doctor, and there are no shortcuts to developing an AI that raises the bar for clinical accuracy, user accessibility, and industry regulation.

EU-GDPR compliantCE MarkISO 27001EN ISO 13485

** As part of the Emergency Use Authorization, the U.S. Government has purchased authorized COVID-19 prescription oral treatments and is making it available to patients at no charge. Other administrative fees may apply.